People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AutoIVF, Inc. | — | Biotechnology | Series A | $8.6M | $17.4M | 2023 |
Alan Penzias at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alan Penzias on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Sable | 1 | 3 |
| Mehmet Toner | 1 | 2 |
| Ravi Kapur | 1 | 2 |
| Denny Sakkas | 1 | 1 |
| Michael Alper | 1 | 1 |
| Erin Schardt | 1 | 1 |
| Dionisios Sakkas | 1 | 1 |
| Thomas Toth | 1 | 1 |
| Mitchell Sayare | 1 | 1 |
| Mitchel Sayare | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.